NBSTRN Tools to Advance Newborn Screening Research and Support Newborn Screening Stakeholders

Abstract

by Kee Chan,Zhanzhi Hu,Lynn W. Bush,Heidi Cope,Ingrid A. Holm,Stephen F. Kingsmore,Kevin Wilhelm,Curt Scharfe andAmy Brower
Int. J. Neonatal Screen. 2023, 9(4), 63; https://doi.org/10.3390/ijns9040063 - 30 Oct 2023
Cited by 8 | Viewed by 1941
Abstract
Rapid advances in the screening, diagnosis, and treatment of genetic disorders have increased the number of conditions that can be detected through universal newborn screening (NBS). However, the addition of conditions to the Recommended Uniform Screening Panel (RUSP) and the implementation of nationwide screening has been a slow process taking several years to accomplish for individual conditions. Here, we describe web-based tools and resources developed and implemented by the newborn screening translational research network (NBSTRN) to advance newborn screening research and support NBS stakeholders worldwide. The NBSTRN’s tools include the Longitudinal Pediatric Data Resource (LPDR), the NBS Condition Resource (NBS-CR), the NBS Virtual Repository (NBS-VR), and the Ethical, Legal, and Social Issues (ELSI) Advantage. Research programs, including the Inborn Errors of Metabolism Information System (IBEM-IS), BabySeq, EarlyCheck, and Family Narratives Use Cases, have utilized NBSTRN’s tools and, in turn, contributed research data to further expand and refine these resources. Additionally, we discuss ongoing tool development to facilitate the expansion of genetic disease screening in increasingly diverse populations. In conclusion, NBSTRN’s tools and resources provide a trusted platform to enable NBS stakeholders to advance NBS research and improve clinical care for patients and their families. Full article
9 pages, 1004 KiB
Open AccessArticle